Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Positive results obtained in AllerVax Cat trial

May 3, 1996

HemispheRx, Helix will codevelop nucleic acid compounds

May 3, 1996

ALT expected to receive streamlined review at FDA

May 3, 1996

Centeon to codevelop Medarex's MDX-33

May 3, 1996

New immunosuppressants from Shionogi

May 3, 1996

Prograf approved for new indication in Japan, launched in France

April 26, 1996

Positive results reported in AllerVax Ragweed trials

April 26, 1996

Terramed receives patent protection for vaccine technology

April 19, 1996

CellCept available in Europe

April 19, 1996

Corixa in-licenses Optivax delivery system for vaccines

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...